ECT2 and prostate cancer: Not only prostate cancer and the above-mentioned cancers, Kai Zhou et al. found that OTUB1 could promote the progression of renal cell carcinoma via mediating the deubiquitination of FOXM1 and up-regulating the expression of ECT-2 (K. Zhou et al., 2020).